Fig 4.

Pooled proportions of patients with post-thrombotic syndrome (PTS) after upper extremity vein thrombosis (UEVT). A, PTS rate for patients treated with direct oral anticoagulants (DOACs), low-molecular-weight heparin (LMWH), and vitamin K antagonists (VKAs) was 12%, 28%, and 25%, respectively. B, PTS rate for patients with cancer, patients without cancer, and patients with cancer and central venous catheter (CVC)-related thrombosis was 25%, 24%, and 19%, respectively. CI, Confidence interval.